Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Brainstem: Control Centers of Medulla01:21

Brainstem: Control Centers of Medulla

The medulla oblongata is a crucial part of the brainstem responsible for controlling various autonomic and involuntary functions. It contains several nuclei, including the olivary, cuneate, gracile, and solitary nuclei.
Olivary Nucleus
The olivary nucleus, or inferior olivary nucleus, is located within the ventrolateral part of the medulla oblongata. It is primarily involved in motor coordination and motor learning. The olivary nucleus receives input from the spinal cord, cerebellum, and motor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gastric myoelectrical activity and autonomic dysfunction in children with IBD and IBS: An electrogastrographic and autonomic correlation study.

Autonomic neuroscience : basic & clinical·2026
Same author

Predicting disease progression in multiple sclerosis with clinically accessible information and technology.

Journal of neurology·2026
Same author

Rome was not built in a day, nor is a resilient clinical autonomic care unit.

Clinical autonomic research : official journal of the Clinical Autonomic Research Society·2026
Same author

Sudoscan® and QSART in the composite autonomic severity scale: complementary approaches to sudomotor assessment in multiple sclerosis.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same author

Long-term outcomes of cladribine tablets in multiple sclerosis: Treatment completion, persistence, and subsequent therapy transitions in Southeast Europe.

Multiple sclerosis and related disorders·2026
Same author

Saccadic Pulses as a Major Sign of Internuclear Ophthalmoplegia in Multiple Sclerosis.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society·2026
Same journal

An overview of the safety and efficacy of sphenopalatine ganglion stimulation for the treatment of chronic cluster headache.

Expert review of neurotherapeutics·2026
Same journal

Multiomics and proteomic insights into Alzheimer's disease biology in Down syndrome.

Expert review of neurotherapeutics·2026
Same journal

Remote deep brain stimulation programming in childhood dystonia: opportunities, challenges, and future directions.

Expert review of neurotherapeutics·2026
Same journal

The differential diagnosis of astrocytic neoplasms and its impact on treatment and prognosis.

Expert review of neurotherapeutics·2026
Same journal

Corticosteroids in withdrawal therapy following medication-overuse headache: a systematic review.

Expert review of neurotherapeutics·2026
Same journal

Clinical efficacy of lacosamide in neuropathic pain: a systematic review of randomized controlled trials.

Expert review of neurotherapeutics·2026
See all related articles

Related Experiment Video

Updated: May 13, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Evaluation of brainstem involvement in multiple sclerosis.

Mario Habek1

  • 1Department of Neurology, Referral Center for Demyelinating Diseases of the Central Nervous System, University Hospital Center Zagreb, Zagreb, Croatia. mhabek@mef.hr

Expert Review of Neurotherapeutics
|March 2, 2013
PubMed
Summary
This summary is machine-generated.

Brainstem damage in multiple sclerosis (MS) significantly predicts disability. Neurophysiological tests, beyond clinical and MRI assessments, offer crucial insights into this brainstem pathology in MS patients.

More Related Videos

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Motor Imagery Brain-Computer Interface in Rehabilitation of Upper Limb Motor Dysfunction After Stroke
09:42

Motor Imagery Brain-Computer Interface in Rehabilitation of Upper Limb Motor Dysfunction After Stroke

Published on: September 1, 2023

Related Experiment Videos

Last Updated: May 13, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Motor Imagery Brain-Computer Interface in Rehabilitation of Upper Limb Motor Dysfunction After Stroke
09:42

Motor Imagery Brain-Computer Interface in Rehabilitation of Upper Limb Motor Dysfunction After Stroke

Published on: September 1, 2023

Area of Science:

  • Neurology
  • Neuroscience
  • Clinical Neurophysiology

Background:

  • Brainstem involvement in multiple sclerosis (MS) is a key predictor of future disability.
  • MS brainstem pathology is often underestimated by clinical evaluation and MRI alone.
  • Neurophysiological tests can reliably predict disability in MS patients.

Purpose of the Study:

  • To review clinical and neuroradiological aspects of brainstem pathology in MS.
  • To explore the role of neurophysiological tests in evaluating brainstem damage in MS.
  • To investigate specific tests like VEPs, SSEPs, ANS, and sleep testing as correlates of brainstem damage.

Main Methods:

  • Review of existing literature on brainstem pathology in MS.
  • Analysis of clinical and neuroradiological findings.
  • Evaluation of neurophysiological tests as ancillary tools for assessing brainstem damage.
  • Focus on vestibular evoked myogenic potentials, trigeminal somatosensory evoked potentials, autonomic nervous system testing, and sleep testing.

Main Results:

  • Brainstem pathology in MS is more prevalent than clinically or radiologically apparent.
  • Neurophysiological tests provide valuable, objective measures of brainstem dysfunction in MS.
  • Specific tests like VEPs, SSEPs, ANS, and sleep studies correlate with brainstem damage.

Conclusions:

  • Brainstem pathology is a critical factor in MS disability.
  • Neurophysiological testing is essential for comprehensive evaluation of brainstem involvement in MS.
  • These ancillary tests improve the understanding and prediction of disability in MS patients.